Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)
Description
CONCLUSION: The positive experience of patients with home natalizumab administration provides an important opportunity to improve the quality of patient care.
